$81.36M
Revenue
$-142.62M
Net Income
-
Gross Margin
-149.34%
Op. Margin
$-278.72M
Free Cash Flow
| Breakdown | TTM (Dec 31, 2025) |
FY 2025 (Dec 31, 2025) |
FY 2024 (Dec 31, 2024) |
FY 2023 (Dec 31, 2023) |
|---|---|---|---|---|
| Total Revenue | $81.36M | $81.36M | $70.84M | $69.56M |
| Revenue Growth % | 0.0% | 14.9% | 1.8% | nan% |
| Cost of Revenue | - | $5.80M | $5.95M | $2.53M |
| Gross Profit | - | $75.56M | $64.89M | $67.03M |
| Gross Margin % | nan% | 92.9% | 91.6% | 96.4% |
| Operating Expenses | $202.86M | $202.86M | $201.49M | $235.54M |
| Research & Development | $104.00M | $104.00M | $109.63M | $127.13M |
| Operating Income | $-121.50M | $-121.50M | $-130.65M | $-165.99M |
| Operating Margin % | -149.3% | -149.3% | -184.4% | -238.6% |
| Interest Expense | $7.99M | $16.27M | $16.60M | $46.33M |
| Interest Income | $8.81M | $8.81M | $12.27M | $10.54M |
| Other Income/Expense | $22.71M | $22.71M | $12.46M | $6.35M |
| Income Before Tax | $-141.61M | $-141.61M | $-156.14M | $-195.42M |
| Income Tax Expense | $1.01M | $1.01M | $166.00K | $39.11M |
| Net Income | $-142.62M | $-142.62M | $-157.85M | $-240.05M |
| Net Margin % | -175.3% | -175.3% | -222.8% | -345.1% |
| Basic EPS | nan | -1.12 | -1.62 | -2.94 |
| Diluted EPS | nan | -1.12 | -1.62 | -2.94 |
| Basic Shares Outstanding | 7.8M | 127.1M | 97.2M | 81.7M |
| Diluted Shares Outstanding | 7.8M | 127.1M | 97.2M | 81.7M |
| Breakdown | FY 2025 (Dec 31, 2025) |
FY 2024 (Dec 31, 2024) |
FY 2023 (Dec 31, 2023) |
|---|---|---|---|
| Cash & Cash Equivalents | $261.34M | $250.87M | $278.60M |
| Inventory | $4.18M | $18.39M | $16.18M |
| Other Current Assets | $6.08M | $9.45M | $5.99M |
| Total Current Assets | $306.33M | $307.39M | $336.29M |
| Property Plant & Equipment | - | $5.08M | $5.62M |
| Other Non-current Assets | $1.22M | $1.16M | $711.00K |
| Total Assets | $323.15M | $321.98M | $354.78M |
| Accounts Payable | $9.18M | $18.03M | $15.57M |
| Accrued Liabilities | $57.99M | $62.44M | $50.63M |
| Total Current Liabilities | $70.16M | $80.47M | $67.67M |
| Deferred Tax Liabilities | $789.00K | $1.91M | - |
| Other Non-current Liabilities | $2.81M | $2.43M | $8.88M |
| Total Liabilities | $508.98M | $524.62M | $503.03M |
| Common Stock | $11.08M | $8.43M | $7.31M |
| Retained Earnings | $-1.64B | $-1.49B | $-1.34B |
| Treasury Stock | $205.00K | $220.00K | $541.00K |
| Total Stockholders Equity | $-185.83M | $-202.64M | $-148.25M |
| Total Liabilities & Equity | $323.15M | $321.98M | $354.78M |
| Breakdown | TTM (Dec 31, 2025) |
FY 2025 (Dec 31, 2025) |
FY 2024 (Dec 31, 2024) |
FY 2023 (Dec 31, 2023) |
|---|---|---|---|---|
| Net Income | $-181.22M | $-142.62M | $-157.85M | $-240.05M |
| Stock-based Compensation | $13.56M | $6.91M | $6.57M | $13.49M |
| Deferred Income Tax | - | - | - | - |
| Change in Receivables | $26.10M | $8.79M | $-4.77M | $-47.79M |
| Change in Inventory | $3.70M | $2.38M | $3.73M | $5.71M |
| Operating Cash Flow | $-277.93M | $-141.17M | $-123.83M | $-118.69M |
| Capital Expenditure | $792.00K | $264.00K | $867.00K | $3.22M |
| Investing Cash Flow | $-133.00K | $395.00K | $-867.00K | $-3.22M |
| Stock Issued | - | $86.28M | $60.51M | - |
| Financing Cash Flow | $245.27M | $150.94M | $97.05M | $73.88M |
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing
Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Total Revenue | $16.43M | $18.46M | $58.30M | $53.93M |
| Operating Expenses | $47.40M | $54.03M | $161.88M | $152.15M |
| Research & Development | $26.80M | $32.50M | $85.82M | $82.53M |
| Operating Income | $-30.97M | $-35.56M | $-103.58M | $-98.22M |
| Interest Expense | $13.39M | $13.12M | $10.88M | $11.94M |
| Interest Income | $2.47M | $3.44M | $6.46M | $9.64M |
| Other Income/Expense | $925.00K | $1.62M | $946.00K | $1.78M |
| Income Before Tax | $-40.97M | $-43.62M | $-134.79M | $-125.09M |
| Income Tax Expense | - | $90.00K | $1.42M | $487.00K |
| Net Income | $-40.97M | $-43.97M | $-136.21M | $-127.12M |
| Basic EPS | -0.30 | -0.42 | -1.14 | -1.35 |
| Diluted EPS | -0.30 | -0.42 | -1.14 | -1.35 |
| Basic Shares Outstanding | $136.45M | $104.82M | $119.24M | $94.39M |
| Diluted Shares Outstanding | $136.45M | $104.82M | $119.24M | $94.39M |
Condensed Consolidated Balance Sheets
| Description | Sep 30, 2025 | Dec 31, 2024 |
|---|---|---|
| Cash & Cash Equivalents | $234.74M | $250.87M |
| Inventory | $18.04M | $18.39M |
| Other Current Assets | $5.52M | $9.45M |
| Total Current Assets | $287.15M | $307.39M |
| Property Plant & Equipment | - | $5.08M |
| Other Non-current Assets | $1.22M | $1.16M |
| Total Assets | $289.76M | $321.98M |
| Accounts Payable | $8.12M | $18.03M |
| Accrued Liabilities | $53.92M | $62.44M |
| Total Current Liabilities | $62.04M | $80.47M |
| Other Non-current Liabilities | $9.39M | $2.43M |
| Total Liabilities | $527.94M | $524.62M |
| Common Stock | $9.76M | $8.43M |
| Retained Earnings | $-1.63B | $-1.49B |
| Treasury Stock | $205.00K | $220.00K |
| Total Stockholders Equity | $-238.18M | $-202.64M |
| Total Liabilities & Equity | $289.76M | $321.98M |
Condensed Consolidated Statements of Cash Flows
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Net Income | $-40.97M | $-43.97M | $-136.21M | $-127.12M |
| Stock-based Compensation | - | - | $6.23M | $4.95M |
| Change in Receivables | - | - | $2.60M | $-1.06M |
| Change in Inventory | - | - | $1.53M | $930.00K |
| Operating Cash Flow | - | - | $-110.05M | $-101.98M |
| Capital Expenditure | - | - | $264.00K | $777.00K |
| Investing Cash Flow | - | - | $-264.00K | $-777.00K |
| Stock Issued | - | - | $42.76M | $60.51M |
| Financing Cash Flow | - | - | $93.86M | $98.17M |
All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-K filings.
Annual data represents full fiscal year results. FY = Fiscal Year ending.